CAR T cell therapy is a promising new gene therapy to treat cancer offered at a select few hospitals, including OHSU Hospital in Portland.
Medicare is considering whether to cover the pricey therapy, which is given for two types of blood cancers. A Eugene oncologist is hoping Medicare will soon cover CAR-T in both the outpatient and in-patient settings.
“The technology is evolving so quickly,” said Dr. Jeff Sharman, who also serves as medical director of hematology research for the US Oncology…
